These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6376650)

  • 41. Attenuation of virulence by P and V plasmids in Vibrio cholerae: strains suitable for oral immunization.
    Sinha VB; Srivastava BS
    Bull World Health Organ; 1979; 57(4):643-7. PubMed ID: 316741
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cholera and other vibrio-associated diarrhoeas.
    WHO Scientific Working Group
    Bull World Health Organ; 1980; 58(3):353-74. PubMed ID: 6968251
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholera: recent updates.
    Weil AA; Ryan ET
    Curr Opin Infect Dis; 2018 Oct; 31(5):455-461. PubMed ID: 30048254
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Designing and Expression of Recombinant Chimeric Protein Containing CtxB and OmpW from Vibrio Cholerae and Evaluation of Its Immunogenicity.
    Vakili A; Mousavi Gargari SL; Nazarian S; Amani J
    Iran J Immunol; 2018 Sep; 15(3):207-220. PubMed ID: 30246696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
    Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
    J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae.
    O'Ryan M; Vidal R; del Canto F; Salazar JC; Montero D
    Hum Vaccin Immunother; 2015; 11(3):584-600. PubMed ID: 25715048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Molecular genetic features of Vibrio cholerae classica strains, that caused the Asiatic cholera epidemic in Russian in 1942].
    Smirnova NI; Cheldyshova NB; Zadnova SP; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2001; (4):12-8. PubMed ID: 11816113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers.
    García L; Jidy MD; García H; Rodríguez BL; Fernández R; Año G; Cedré B; Valmaseda T; Suzarte E; Ramírez M; Pino Y; Campos J; Menéndez J; Valera R; González D; González I; Pérez O; Serrano T; Lastre M; Miralles F; Del Campo J; Maestre JL; Pérez JL; Talavera A; Pérez A; Marrero K; Ledón T; Fando R
    Infect Immun; 2005 May; 73(5):3018-24. PubMed ID: 15845509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction of genetically marked Vibrio cholerae O1 vaccine strains.
    Ketley JM; Michalski J; Galen J; Levine MM; Kaper JB
    FEMS Microbiol Lett; 1993 Jul; 111(1):15-21. PubMed ID: 8359676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation and suppression of the proinflammatory immune response by Vibrio cholerae toxins.
    Satchell KJ
    Microbes Infect; 2003 Nov; 5(13):1241-7. PubMed ID: 14623020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Summary of the 29th United States-Japan joint Conference on Cholera and Related Diarrheal Diseases.
    Lang DR; Guerrant RL
    J Infect Dis; 1995 Jan; 171(1):8-12. PubMed ID: 7798685
    [No Abstract]   [Full Text] [Related]  

  • 52. Vaccine development for the control of cholera and related toxin-induced diarrhoeal diseases.
    Holmgren J; Svennerholm AM
    Ciba Found Symp; 1985; 112():242-70. PubMed ID: 3891255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cloned cholera enterotoxin genes in study and prevention of cholera.
    Kaper JB; Levine MM
    Lancet; 1981 Nov; 2(8256):1162-3. PubMed ID: 6118594
    [No Abstract]   [Full Text] [Related]  

  • 54. Animal models for immunoglobulin A secretion.
    Keren DF; Suckow MA
    Methods Enzymol; 1994; 235():140-55. PubMed ID: 8057892
    [No Abstract]   [Full Text] [Related]  

  • 55. Recent developments in cholera.
    Shears P
    Curr Opin Infect Dis; 2001 Oct; 14(5):553-8. PubMed ID: 11964875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Method of obtaining and the characteristics of an antiserum that neutralizes Escherichia coli and Vibrio cholera enterotoxins].
    Likhoded VG; Tabachnik AL; Temper RM
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):36-40. PubMed ID: 4137436
    [No Abstract]   [Full Text] [Related]  

  • 57. A De in the life of cholera.
    Hall RH
    Indian J Med Res; 2011 Feb; 133(2):146-52. PubMed ID: 21415488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Methods of biologic testing of enterotoxins].
    Vartanian IuP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Mar; (3):19-24. PubMed ID: 6264715
    [No Abstract]   [Full Text] [Related]  

  • 59. Vasoactive drugs on intestinal fluid secretion induced by Vibrio cholera toxin.
    Strombeck DR
    Life Sci I; 1971 Dec; 10(24):1403-7. PubMed ID: 5146323
    [No Abstract]   [Full Text] [Related]  

  • 60. On the possible role of intestinal hormones as the diarrhoeagenic messenger in cholera.
    Osaka M; Fujita T; Yanatori Y
    Virchows Arch B Cell Pathol; 1975 Sep; 18(4):287-96. PubMed ID: 809916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.